Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet
Description
This is an archive of https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext from Wednesday 28, July 2021